Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone

December 14, 2018 updated by: Hamidreza Shemshaki, Isfahan University of Medical Sciences
The purpose of this study is to compare ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone

Study Overview

Detailed Description

While there are some retrospective studies compared ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone, there is not randomized clinical trial in this regard. This study was designed to compare the efficacy and safety of ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ureteral stone who underwent ureteroscopy

Exclusion Criteria:

  • transplant kidney
  • coagulopathy disorders
  • history of ureteral stenosis
  • skeletal disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ureteroscopy with safety guide-wire
ureteroscopy is done with use of safety guide-wire, this is a one procedure that we use safety guide wire (as a device) during ureteroscopy
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
Placebo Comparator: ureteroscopy alone
ureteroscopy is done without use of safety guide-wire, this is a one procedure that we don"t use safety guide wire (as a device) during ureteroscopy
ureteroscopy without use of safety guide-wire in treatment of ureteral stone
ureteroscopy without use of safety guide-wire in treatment of ureteral stone
Active Comparator: with safety guide-wire
ureteroscopy is done with use of safety guide-wire, this is a one procedure that we use safety guide wire (as a device) during ureteroscopy
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
Placebo Comparator: without safety guide-wire
ureteroscopy is done without use of safety guide-wire, this is a one procedure that we don"t use safety guide wire (as a device) during ureteroscopy
ureteroscopy without use of safety guide-wire in treatment of ureteral stone
ureteroscopy without use of safety guide-wire in treatment of ureteral stone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stone free rate
Time Frame: 3 months after surgery
rate of patients without any residue of stone
3 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operation time
Time Frame: at time of surgery
the time between insertion of ureteroscopy till insertion of catheter
at time of surgery
grade of kidney hydronephrosis
Time Frame: 3 months after surgery
grade of hydronephrosis is classified as: 0-4 grades
3 months after surgery
ureteral injury
Time Frame: at time of surgery
ureteral injury is classified as: Mucosal abrasion, Ureteral perforation, Intussusception / avulsion
at time of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Abbas Basiri, prof, Shahid Beheshty University of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

April 19, 2017

First Submitted That Met QC Criteria

October 30, 2018

First Posted (Actual)

October 31, 2018

Study Record Updates

Last Update Posted (Actual)

December 19, 2018

Last Update Submitted That Met QC Criteria

December 14, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ureteral Calculi

Clinical Trials on ureteroscopy with safety guide-wire

3
Subscribe